CYTRのニュース
CytRx to rename as LadRx 2022/09/23 13:39:47 Seeking Alpha
CytRx (CYTR) said it is renaming as LadRx Corporation, effective Sept
European patent office awards CytRx patent for LADR platform 2022/09/07 14:26:26 Seeking Alpha
CytRx Corporation (CYTR) said on Wednesday it had been awarded a patent by the European Patent Office that covers the incorporation of the LADR backbone in a variety of drug…
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock 2022/05/19 20:30:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 pm Eastern Time on May 20, 2022. The outstanding share
CytRx to absorb subsidiary Centurion BioPharma; former CEO retires from board 2022/03/09 17:24:51 Seeking Alpha
CytRx (CYTR) said it would merge with its subsidiary Centurion BioPharma as the company looks to benefit from Centurion''s LADR platform, which is being developed for localized delivery…
Analyzing Vir Biotechnology (NASDAQ:VIR) & CytRx (OTCMKTS:CYTR) 2021/12/24 10:08:45 Dakota Financial News
Vir Biotechnology (NASDAQ:VIR) and CytRx (OTCMKTS:CYTR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, dividends, risk and profitability. Volatility & Risk Vir Biotechnology has a beta of -1.48, suggesting that its stock price is 248% []
Trading - Financial Survey: Vir Biotechnology vs. CytRx 2021/12/22 08:59:07 Business Mag
Vir Biotechnology and CytRx are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst
Financial Survey: Vir Biotechnology (NASDAQ:VIR) vs. CytRx (OTCMKTS:CYTR) 2021/12/22 08:46:42 ETF Daily News
Vir Biotechnology (NASDAQ:VIR) and CytRx (OTCMKTS:CYTR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Volatility and Risk Vir Biotechnology has a beta of -1.48, indicating that its stock price is 248% [] The post Financial Survey: Vir Biotechnology (NASDAQ:VIR) vs. CytRx (OTCMKTS:CYTR) appeared first on ETF Daily News .
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock 2022/05/19 20:30:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 pm Eastern Time on May 20, 2022. The outstanding share
CytRx to absorb subsidiary Centurion BioPharma; former CEO retires from board 2022/03/09 17:24:51 Seeking Alpha
CytRx (CYTR) said it would merge with its subsidiary Centurion BioPharma as the company looks to benefit from Centurion''s LADR platform, which is being developed for localized delivery…
Analyzing Vir Biotechnology (NASDAQ:VIR) & CytRx (OTCMKTS:CYTR) 2021/12/24 10:08:45 Dakota Financial News
Vir Biotechnology (NASDAQ:VIR) and CytRx (OTCMKTS:CYTR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, dividends, risk and profitability. Volatility & Risk Vir Biotechnology has a beta of -1.48, suggesting that its stock price is 248% []
Trading - Financial Survey: Vir Biotechnology vs. CytRx 2021/12/22 08:59:07 Business Mag
Vir Biotechnology and CytRx are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst
Financial Survey: Vir Biotechnology (NASDAQ:VIR) vs. CytRx (OTCMKTS:CYTR) 2021/12/22 08:46:42 ETF Daily News
Vir Biotechnology (NASDAQ:VIR) and CytRx (OTCMKTS:CYTR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Volatility and Risk Vir Biotechnology has a beta of -1.48, indicating that its stock price is 248% [] The post Financial Survey: Vir Biotechnology (NASDAQ:VIR) vs. CytRx (OTCMKTS:CYTR) appeared first on ETF Daily News .